Cellebrite DI (CLBT) Revenue (2020 - 2025)

Cellebrite DI's Revenue history runs 6 years deep, the most recent figure standing at $128.8 million for Q4 2025.

• In Q4 2025, Revenue rose 18.13% year-over-year to $128.8 million; the TTM figure through Dec 2025 stood at $475.7 million (up 18.56% YoY), while the FY2025 annual figure was $475.7 million, up 18.56% from the prior year.
• Revenue was $128.8 million for Q4 2025 at Cellebrite DI, up from $126.0 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $128.8 million in Q4 2025 to a low of $53.3 million in Q1 2021.
• Historically, Revenue has averaged $85.9 million across 5 years, with a median of $80.4 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Revenue increased 5.75% in 2022, then rose 26.94% in 2024.
• A 5-year view of Revenue shows it stood at $67.9 million in 2021, then increased by 9.0% to $74.0 million in 2022, then increased by 25.66% to $93.0 million in 2023, then grew by 17.24% to $109.0 million in 2024, then climbed by 18.13% to $128.8 million in 2025.
• The last three Revenue figures came in at $128.8 million (Q4 2025), $126.0 million (Q3 2025), and $113.3 million (Q2 2025), per Business Quant data.